Browsing: Mene Pangalos
New data says AstraZeneca booster generates increased immune & antibody response to SARS-CoV-2 variants, incl Omicron
By Lion's Den
Positive results from a preliminary analysis of an ongoing safety and immunogenicity trial (D7220C00001) showed that AstraZeneca COVID-19 Vaccine, when…
AstraZeneca’s COVID-19 vaccine (ChAdOx1-S [Recombinant]) significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant (B.1.1.529) following a third dose…
AstraZeneca’s long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19
By Lion's Den
AstraZeneca’s long-acting antibody combination (tixagevimab co-packaged with cilgavimab called AZD7442), has received emergency use authorization (EUA) in the US for…
AstraZeneca COVID-19 Vaccine showed no increased incidence of thrombosis with thrombocytopenia after second dose Incidence rates were comparable to those among unvaccinated individuals
By Lion's Den
Rates of the very rare clotting disorder, thrombosis with thrombocytopenia syndrome (TTS), following a second dose of AstraZeneca’s COVID-19 Vaccine…